Be in the know. 16 key reads for Tuesday…

  1. Beaten-down small-cap stocks are roaring back. Why they could soar in 2024. (marketwatch)
  2. Biotech CEOs Are Buying Up Their Surging Stocks (barrons)
  3. Chinese gaming firms unveil share buybacks after regulatory move unnerves investors (reuters)
  4. China’s potential new gaming rules will hit smaller developers more, analyst says (cnbc)
  5. China Is Softening Stance on Gaming After $80 Billion Rout (bloomberg)
  6. Alibaba promotes millennials to key e-commerce leadership roles as it repositions to fend off rivals (scmp)
  7. Bristol Myers to Buy RayzeBio in $4.1 Billion Deal (barrons)
  8. AstraZeneca to Acquire Gracell in $1.2 Billion Deal to Further Cell Therapy Goals (barrons)
  9. Intel’s $25 billion investment in Israel ‘important and significant’ says country’s finance minister (marketwatch)
  10. Home prices may pick up speed after the Fed cuts rates with 88% of the housing market still overvalued, Fitch says (businessinsider)
  11. More OPEC cuts, a US production boom, and a market share war: Here’s what oil markets are anticipating in 2024 (businessinsider)
  12. A new all-time high awaits the S&P 500 as investors ‘buy into the euphoria,’ says this strategist (marketwatch)
  13. China approves 105 online games, says it fully supports industry after NetEase, Tencent rout (marketwatch)
  14. The Big Read. The art of superforecasting: how FT readers fared against the experts in 2023 (ft)
  15. AstraZeneca set to make one of its first acquisitions in China (ft)
  16. China’s Yuan Is Quietly Gaining Ground (wsj)